Home
Live Updates
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q4 2023 Earnings Call Transcript : comparemela.com
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q4 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, welcome to the Arrowhead Pharmaceuticals Conference Call. Throughout today's recorded presentation, all participants will be in a listen-only.
Related Keywords
Copenhagen ,
Køavn ,
Denmark ,
United States ,
American ,
Daniel Gaudet ,
Ken Myszkowski ,
Chris Anzalone ,
Tracy Oliver ,
Steven Nissen ,
Vince Anzalone ,
Edward Tenthoff ,
James Hamilton ,
Piper Sandler ,
Patrick Obrien ,
Mani Foroohar ,
Maury Raycroft ,
Ellie Merle ,
Securities Exchange ,
Nasdaq ,
Copenhagen University Hospital ,
Arrowhead Pharmaceuticals Conference Call ,
University Of Copenhagen ,
Vascular Institute ,
American Heart Association ,
Amgen ,
Arrowhead Pharmaceuticals Inc ,
Arrowhead Pharmaceuticals ,
Call Transcript November ,
Arrowhead Pharmaceuticals Conference ,
Vice President ,
Investor Relations ,
Javier San Martin ,
Chief Medical Officer ,
Translational Medicine ,
Chief Financial Officer ,
Chief Commercial Officer ,
Patricko Brien ,
Chief Operating Officer ,
General Counsel ,
Securities Act ,
Securities Exchange Act ,
American Heart Meeting ,
Javier San ,
San Martin ,
Chief Physician ,
Chief Academic Officer ,
Cleveland Clinic ,
June Analyst Rd Day ,
Get Citizenship ,
comparemela.com © 2020. All Rights Reserved.